Clinical Trial Support
Genetic screening to maximize clinical trial success.
Unlock the power of pharmacogenomics to de-risk your clinical trial.
Clinical research organizations use Genomind to identify ideal participants for clinical trials by screening for genetic variants that influence drug metabolism, response, and tolerability.
Pharmacogenomic Profiling for Targeted Patient Enrollment
With over a decade of PGx expertise, Genomind helps clinical trial sponsors optimize clinical trial design, patient selection, and outcome reliability through rapid, high-quality pharmacogenomic insights.
Identify Ideal Trial Participants
Leverage our award-winning lab and logistics infrastructure to screen patients for key gene variants pre-enrollment or mid-trial.
Accelerate Enrollment and Improve Retention
Get detailed, trial-specific genomic reports and cohort analytics to guide patient inclusion, stratification, or adaptive design changes.
Custom Reporting & Analytics
Work with Genomind’s clinical and scientific team to identify PGx-relevant genes based on your investigational compound’s metabolic profile.
Experts in Pharmacogenetic Testing
Your Trusted PGx Partner for Smarter Clinical Trials
Here’s why Genomind is the best option for your next clinical trial.
- > 400,000 patients tested: Decades-long expertise in pharmacogenetics
- Capacity to Scale: Plenty of excess capacity to quickly scale to large clinical trial cohorts
- Accelerated Turnaround: Tests can be analyzed in 2–3 business days post sample receipt
- Customized Gene Panels: Tailored for trial-specific pharmaceuticals
- Unmatched Genetic Reports that can efficiently identify ideal trial participants
Contact Us
Whether you are a pharmaceutical company, biotech organization, clinical research organization (CRO), or someone else, we’d love to connect and learn more about your project.
"*" indicates required fields